In Arizona, Axolotl Biologix, a regenerative human cell and tissue medical technologies company, entered into an exclusive worldwide license agreement with Protein Genomics, Inc., an R&D company focused on biopolymers for applications in wound healing and tissue regeneration. The license agreement allows Axolotl Biologix to use Protein Genomics’ patents and manufacturing knowledge for a biomimetic skin substitute made from biomaterial called Elastropin. This will help grow and expand Axolotl Biologix’s burn, surgical and wound treatment products. Axolotl Biologix is also acquiring Protein Genomics’ research laboratory in Flagstaff as part of the agreement, and gave a heads up that they plan on filing three new patents in the very near future, so stay tuned.
Home Biomaterials Axolotl Biologix Acquires Protein Genomics’ Research Lab and Signs License Agreement
Latest article
World Animal Protection launches AI-Powered cultivated meat chatbot
In London, animal advocacy group World Animal Protection has partnered with AI software company PubTrawlr to unveil Cultivator, the first-ever chatbot dedicated to cultivated...
DOE awards Hempitecture $8.42 million to boost hemp fiber manufacturing in Tennessee
In Idaho, sustainable building materials firm Hempitecture has been awarded $8.42 million in funding from the U.S. Department of Energy under the Biden-Harris Administration’s...
CJ Biomaterials PHA earns compostability certification
In Massachusetts, CJ Biomaterials, a division of South Korea's CJ CheilJedang, has received certification from the Biodegradable Products Institute (BPI) for its range of...